Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 27 recruiting now early-phase tilt #96 of 28,707 conditions

Smoking: early-phase trial registry

27 of 124 indexed Smoking trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #96 of 28,707 conditions by registered trial count.

124 US clinical trials · 27 currently recruiting · #96 of 28,707 conditions by registered trial count

Smoking: 124 US clinical trials tracked, 27 recruiting.

Smoking is the subject of 124 registered US clinical trials on ClinicalTrials.gov, 27 of them currently open to new participants. 13 are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most active sponsor is RAI Services Company, running 9 of these trials.

Enrollment posture brief

Registry condition smoking

OPEN 27 | RECR 22% | LATE 13 | EARLY 22 | RANK #96 | SPON 9

Nearest open-share peer: Plaque Psoriasis (22% recruiting · 46 trials)

Head and Neck Squamous Cell 56.8%Advanced Cancer36.6%Ulcerative Colitis36.6%Low Back Pain25.2%Smoking (this)22%
Open-enrollment share among volume-matched conditions near Smoking

Smoking lists 27 open slots (22% of 124 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Smoking on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Smoking is recruiting below its size-band peers.

    27 of 124 indexed trials (21.8%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Smoking trials is spread across many organizations.

    RAI Services Company accounts for 9 of 124 trials (7.3%). 62 distinct sponsors appear on at least one study for this condition label.

  3. Typical Smoking enrolment sits around 165 participants.

    Median target enrolment is 165 among the 124 trials that report a genuine target (sentinel values excluded). 48 of those (38.7%) plan for fewer than 100 participants.

  4. Smoking research is mostly interventional.

    113 interventional and 11 observational studies make up this index (91.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 19Phase 213Phase 34Phase 49

Open and recent trials

124 total, page 2 of 3

COMPLETED NA 900 participants

Cessation Service Use and Effectiveness for Hospitalized Smokers

Kaiser Permanente

NCT01236079

COMPLETED NA 864 participants

A Medical Assistant-Based Program to Promote Healthy Behaviors in Primary Care

The University of Texas Health Science Center at San Antonio

NCT00273806

COMPLETED 775 participants

Survey of Smokers Treated in the Emergency Department (ED) on Ownership and Usage of Cell Phones

Yale University

NCT01820533

COMPLETED NA 685 participants

Improving Tobacco Treatment Rates for Cancer Patients Who Smoke

Abramson Cancer Center at Penn Medicine

NCT04738643

COMPLETED NA 672 participants

A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2

Philip Morris Products S.A.

NCT02649556

COMPLETED NA 638 participants

Clinical Outcomes of a Nationwide, Naturalistic E-Cig Trial (CONNECT)

Medical University of South Carolina

NCT03453385

COMPLETED NA 633 participants

Connect to Quit for Smoking

University of Pittsburgh

NCT01299896

COMPLETED 617 participants

Asian Youth and Tobacco Control Survey

M.D. Anderson Cancer Center

NCT00642317

COMPLETED NA 577 participants

Telephone Care Coordination for Smokers in VA Mental Health Clinics

VA Office of Research and Development

NCT00724308

COMPLETED Phase 2 536 participants

Proactive Health Intervention for Tobacco Users (Get PHIT)

Kaiser Permanente

NCT00169260

COMPLETED Phase 2 522 participants

Study of TA-NIC to Assess the Efficacy and Safety of the Vaccine as an Aid to Smoking Cessation

Celtic Pharma Development Services

NCT00633321

COMPLETED Phase 4 517 participants

Identifying Treatments to Motivate Smokers to Quit

University of Wisconsin, Madison

NCT01122238

COMPLETED NA 501 participants

Tobacco Status Project: Social Media Intervention for Young Adult Smokers

University of California, San Francisco

NCT02207036

COMPLETED Phase 4 463 participants

Bupropion SR Plus Counseling for Smoking Cessation

University of Wisconsin, Madison

NCT01621009

COMPLETED NA 400 participants

Improving Health Behaviors Through Telephone Linked Care

American Academy of Family Physicians

NCT00314197

COMPLETED Phase 2 333 participants

Efficacy of Naltrexone in Women's Smoking Cessation

University of Chicago

NCT00271024

COMPLETED 330 participants

HIV-related Accelerated Aging of the Airway Epithelium

Weill Medical College of Cornell University

NCT01974219

COMPLETED NA 300 participants

Strategies to Avoid Returning to Smoking

University of Pittsburgh

NCT00757068

COMPLETED NA 282 participants

Evaluating the Effects of Supplemental Vitamin C on Infant Lung Function in Pregnant Smoking Women

Oregon Health and Science University

NCT00632476

COMPLETED NA 270 participants

Protecting the 'Hood Against Tobacco

University of California, San Francisco

NCT00187603

COMPLETED Phase 3 255 participants

Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD)

University of Cincinnati

NCT00253747

COMPLETED Phase 4 248 participants

Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease

Massachusetts General Hospital

NCT00181818

COMPLETED Phase 1 240 participants

Group Counseling for Smoking Cessation

American University

NCT00104481

COMPLETED Phase 3 232 participants

Tobacco Tactics Website for Operating Engineers

University of Michigan

NCT01124110

COMPLETED NA 210 participants

CSD170304: Study to Assess Nicotine Uptake in Smokers From Electronic and Combustible Cigarettes

RAI Services Company

NCT03294356

COMPLETED NA 196 participants

Innovative Smartphone Application of a New Behavioral Method to Quit Smoking: Pilot Trial (Smart Quit)

Fred Hutchinson Cancer Center

NCT01812070

COMPLETED NA 194 participants

CSD210903: A Study to Determine Subject Puffing Patterns of a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in an Ambulatory Setting

RAI Services Company

NCT05307822

COMPLETED Phase 4 179 participants

Smoking Tobacco and Drinking Study

University of California, San Francisco

NCT03163303

COMPLETED 178 participants

Physiological Responses in Tobacco Chippers

Oregon Health and Science University

NCT01237834

COMPLETED NA 165 participants

A Facebook Intervention for Young Sexual and Gender Minority Smokers

University of California, San Francisco

NCT03259360

COMPLETED Phase 4 120 participants

CPT-SMART for Treatment of PTSD and Cigarette Smoking

VA Office of Research and Development

NCT03978442

COMPLETED 117 participants

Alpha-1 Carrier Genomics Study

Medical University of South Carolina

NCT02810327

COMPLETED NA 117 participants

The Moment Study: Mixed Method E-cigarette Study

Truth Initiative

NCT02261363

COMPLETED Phase 2 114 participants

N-acetylcysteine for Tobacco Use Disorder

Medical University of South Carolina

NCT02737358

COMPLETED NA 114 participants

CSD170501: Study to Assess Biomarkers of Tobacco Exposure in Smokers During In-Clinic Confinement Switch to an Electronic Cigarette

RAI Services Company

NCT03170674

COMPLETED Phase 2 110 participants

Computer-Assisted Intervention for Smoking During Pregnancy

Wayne State University

NCT01028131

COMPLETED Phase 4 101 participants

Long-term Varenicline Treatment for Smoking Cessation

University of Wisconsin, Madison

NCT00828113

COMPLETED NA 100 participants

Electronic Cigarettes (E-cigarettes) as a Harm Reduction Strategy

NYU Langone Health

NCT02628964

COMPLETED Phase 2 100 participants

Modeling Stress-precipitated Smoking Behavior for Medication Development

Yale University

NCT00773357

COMPLETED Early Phase 1 99 participants

Hollings Cancer Center Varenicline Sampling Study

Medical University of South Carolina

NCT03742154

COMPLETED Phase 2 99 participants

Oxidative Stress and Vitamin E Requirements

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT00067899

COMPLETED 88 participants

Parent Willingness to Participate in Tobacco Trials in the Pediatric Clinical Setting

St. Jude Children's Research Hospital

NCT01673243

COMPLETED NA 83 participants

A Pilot Randomized Controlled Trial of Financial Incentives, Text Messaging, and Usual Care for Homeless Smokers

Massachusetts General Hospital

NCT02565381

COMPLETED NA 76 participants

Increasing Cessation Motivation and Treatment Engagement Among Smokers in Pain

Syracuse University

NCT03996902

COMPLETED NA 75 participants

CSD200907: A Study to Assess Elements of Abuse Liability for a Heated Tobacco Product With Four Non-Combusted Cigarette Variants

RAI Services Company

NCT05114863

COMPLETED Early Phase 1 64 participants

Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices

Masonic Cancer Center, University of Minnesota

NCT04740008

COMPLETED NA 61 participants

Connecting Alaska Native People to Quit Smoking

Mayo Clinic

NCT03645941

COMPLETED NA 59 participants

Smoking Cessation Smartphone App for Cancer Patients (Quit2Heal Study)

Fred Hutchinson Cancer Center

NCT03600038

COMPLETED NA 56 participants

Young Adults' Reactions to Low Nicotine Cigarette Advertising

Abramson Cancer Center at Penn Medicine

NCT04906148

COMPLETED NA 51 participants

Effects of Sulforaphane (SFN) on Immune Response to Live Attenuated Influenza Virus in Smokers and Nonsmokers

University of North Carolina, Chapel Hill

NCT01269723

← Previous Page 2 of 3 Next →

Phase Distribution

PhaseTrial count
Phase 1 9
Phase 2 13
Phase 3 4
Phase 4 9

Named interventions

Most-linked intervention names on Smoking records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
5 trials
Product D Other
4 trials
Product C Other
4 trials
Product B Other
4 trials
Nicotine Patch Drug
4 trials
Product A Other
3 trials
varenicline Drug
2 trials
Product E Other
2 trials

US sites by state

Facility locations filed on Smoking trials. A trial with sites in several states counts in each.

New York 16 trials
Texas 14 trials
California 10 trials
Washington 9 trials
South Carolina 9 trials
Minnesota 9 trials
Pennsylvania 8 trials
Oregon 8 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Smoking page

124 registered trials, 27 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Smoking condition card totals 124 registered trials; most-linked intervention Placebo; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.